| scholarly article | Q13442814 |
| P50 | author | Wendel Wohlleben | Q30828135 |
| Delina Lyon | Q59687923 | ||
| Robert Landsiedel | Q88172378 | ||
| P2093 | author name string | Nicole Neubauer | |
| Josje H E Arts | |||
| Ursula G Sauer | |||
| Karin Wiench | |||
| David Warheit | |||
| Athena M Keene | |||
| Muhammad-Adeel Irfan | |||
| Karin Michel | |||
| Monika Maier | |||
| Reinhard Kreiling | |||
| Thomas Petry | |||
| P2860 | cites work | Nanoscale reference materials for environmental, health and safety measurements: needs, gaps, and opportunities | Q23909697 |
| Development of risk-based nanomaterial groups for occupational exposure control | Q23912281 | ||
| Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass | Q24815080 | ||
| A review and perspective of existing research on the release of nanomaterials from solid nanocomposites | Q26860164 | ||
| Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening | Q27012652 | ||
| Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment | Q27921845 | ||
| Lung inflammation and lack of genotoxicity in the comet and micronucleus assays of industrial multiwalled carbon nanotubes Graphistrength(©) C100 after a 90-day nose-only inhalation exposure of rats | Q28382990 | ||
| Carbon black and titanium dioxide nanoparticles induce distinct molecular mechanisms of toxicity | Q28384562 | ||
| Concern-driven integrated approaches to nanomaterial testing and assessment--report of the NanoSafety Cluster Working Group 10 | Q28384830 | ||
| Time course of lung retention and toxicity of inhaled particles: short-term exposure to nano-Ceria | Q28387293 | ||
| Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials | Q28391170 | ||
| Grouping and Read-Across Approaches for Risk Assessment of Nanomaterials | Q28392642 | ||
| Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation | Q28392757 | ||
| Inflammogenic effect of well-characterized fullerenes in inhalation and intratracheal instillation studies | Q28394563 | ||
| Biokinetics and effects of barium sulfate nanoparticles | Q28397069 | ||
| Mechanism-based genotoxicity screening of metal oxide nanoparticles using the ToxTracker panel of reporter cell lines | Q28397895 | ||
| Copper Oxide Nanoparticles Are Highly Toxic: A Comparison between Metal Oxide Nanoparticles and Carbon Nanotubes | Q28651579 | ||
| Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study | Q29547366 | ||
| Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties | Q29615453 | ||
| Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months | Q29615609 | ||
| Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures | Q29615718 | ||
| Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles | Q33299421 | ||
| Refinement and reduction of acute oral toxicity testing: a critical review of the use of cytotoxicity data. | Q33967186 | ||
| Subchronic inhalation toxicity of amorphous silicas and quartz dust in rats | Q34494800 | ||
| Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays | Q34686914 | ||
| Dissolution of man-made vitreous fibers in rat alveolar macrophage culture and Gamble's saline solution: influence of different media and chemical composition of the fibers | Q35032071 | ||
| Differential bioreactivity of neutral, cationic and anionic polystyrene nanoparticles with cells from the human alveolar compartment: robust response of alveolar type 1 epithelial cells | Q35680554 | ||
| Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black | Q37037991 | ||
| Genotoxicity of nano/microparticles in in vitro micronuclei, in vivo comet and mutation assay systems | Q37350056 | ||
| Nanoparticles and the brain: cause for concern?. | Q37635910 | ||
| Review of fullerene toxicity and exposure--appraisal of a human health risk assessment, based on open literature | Q37783718 | ||
| Fullerene c60: inhalation hazard assessment and derivation of a period-limited acceptable exposure level | Q37920508 | ||
| Granular biodurable nanomaterials: No convincing evidence for systemic toxicity | Q38254509 | ||
| Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies | Q38285750 | ||
| Effect of particle agglomeration in nanotoxicology | Q38331210 | ||
| Review of nanomaterial aging and transformations through the life cycle of nano-enhanced products | Q38364140 | ||
| Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making | Q38384527 | ||
| A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). | Q38394202 | ||
| Nanostructured calcium silicate hydrate seeds accelerate concrete hardening: a combined assessment of benefits and risks | Q38417102 | ||
| In vitro and in vivo genotoxicity investigations of differently sized amorphous SiO2 nanomaterials | Q38812853 | ||
| A functional assay-based strategy for nanomaterial risk forecasting | Q38983324 | ||
| Gene toxicity studies on titanium dioxide and zinc oxide nanomaterials used for UV-protection in cosmetic formulations | Q39647742 | ||
| Genotoxicity, cytotoxicity, and reactive oxygen species induced by single-walled carbon nanotubes and C(60) fullerenes in the FE1-Mutatrade markMouse lung epithelial cells | Q39962614 | ||
| MWCNTs of different physicochemical properties cause similar inflammatory responses, but differences in transcriptional and histological markers of fibrosis in mouse lungs | Q42703002 | ||
| Amorphous silica nanoparticles do not induce cytotoxicity, cell transformation or genotoxicity in Balb/3T3 mouse fibroblasts | Q42803153 | ||
| Relating colloidal stability of fullerene (C60) nanoparticles to nanoparticle charge and electrokinetic properties. | Q43256839 | ||
| Applicability of rat precision-cut lung slices in evaluating nanomaterial cytotoxicity, apoptosis, oxidative stress, and inflammation. | Q45899432 | ||
| Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles | Q47403231 | ||
| Ninety-day inhalation toxicity study with a vapor grown carbon nanofiber in rats | Q47771159 | ||
| Sameness: The regulatory crux with nanomaterial identity and grouping schemes for hazard assessment. | Q50967617 | ||
| A critical appraisal of existing concepts for the grouping of nanomaterials. | Q51420432 | ||
| Generation and characterization of test atmospheres with nanomaterials. | Q51704211 | ||
| Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology. | Q51813736 | ||
| Interactions between suspension characteristics and physicochemical properties of silver and copper oxide nanoparticles: a case study for optimizing nanoparticle stock suspensions using a central composite design. | Q53349806 | ||
| A strategy for grouping of nanomaterials based on key physico-chemical descriptors as a basis for safer-by-design NMs | Q55167377 | ||
| Toxicity of nanoparticles embedded in paints compared to pristine nanoparticles, in vitro study | Q57009976 | ||
| Where Are We Heading in Nanotechnology Environmental Health and Safety and Materials Characterization? | Q58467116 | ||
| A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats | Q72210150 | ||
| Five-day inhalation toxicity study of three types of synthetic amorphous silicas in Wistar rats and post-exposure evaluations for up to 3 months | Q80380489 | ||
| Comparing fate and effects of three particles of different surface properties: nano-TiO(2), pigmentary TiO(2) and quartz | Q83121522 | ||
| Atomic force microscopy and analytical ultracentrifugation for probing nanomaterial protein interactions | Q84111095 | ||
| Influence of dispersive agent on nanomaterial agglomeration and implications for biological effects in vivo or in vitro | Q86136882 | ||
| Mapping the biological oxidative damage of engineered nanomaterials | Q86169343 | ||
| Possible Chemical Source of Discrepancy between in Vitro and in Vivo Tests in Nanotoxicology Caused by Strong Adsorption of Buffer Components | Q86486945 | ||
| Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance | Q94706699 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | decision making | Q1331926 |
| nanomaterial | Q967847 | ||
| decision-making framework | Q119711780 | ||
| P304 | page(s) | 234-261 | |
| P577 | publication date | 2015-12-10 | |
| P1433 | published in | Regulatory Toxicology and Pharmacology | Q2138805 |
| P1476 | title | Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice | |
| P478 | volume | 76 |
| Q53186081 | A Mechanistic Model for Predicting Lung Inflammogenicity of Oxide Nanoparticles. |
| Q111312606 | A framework for grouping and read-across of nanomaterials- supporting innovation and risk assessment |
| Q38633374 | A quantitative framework to group nanoscale and microscale particles by hazard potency to derive occupational exposure limits: proof of concept evaluation |
| Q38978917 | A review of toxicity studies on graphene-based nanomaterials in laboratory animals. |
| Q92894424 | A risk assessment framework for self-management of poorly soluble low toxic nanomaterials |
| Q47410600 | Aligning nanotoxicology with the 3Rs: What is needed to realise the short, medium and long-term opportunities? |
| Q109728984 | An Integrated Approach to Testing and Assessment to Support Grouping and Read-Across of Nanomaterials After Inhalation Exposure |
| Q28388825 | An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials |
| Q39043533 | Application of Bayesian networks for hazard ranking of nanomaterials to support human health risk assessment |
| Q50151964 | Barium sulfate micro- and nanoparticles as bioinert reference material in particle toxicology. |
| Q52638280 | Characterizing risk assessments for the development of occupational exposure limits for engineered nanomaterials. |
| Q90456302 | Chemical and Colloidal Dynamics of MnO2 Nanosheets in Biological Media Relevant for Nanosafety Assessment |
| Q41072766 | Comparative short-term inhalation toxicity of five organic diketopyrrolopyrrole pigments and two inorganic iron-oxide-based pigments |
| Q88255481 | Criteria for grouping of manufactured nanomaterials to facilitate hazard and risk assessment, a systematic review of expert opinions |
| Q38658065 | Current Knowledge on the Use of Computational Toxicology in Hazard Assessment of Metallic Engineered Nanomaterials |
| Q47282095 | Decision tree models to classify nanomaterials according to the DF4nanoGrouping scheme |
| Q42367089 | Green Toxicology: a strategy for sustainable chemical and material development |
| Q58700801 | Grouping of nanomaterials to read-across hazard endpoints: from data collection to assessment of the grouping hypothesis by application of chemoinformatic techniques |
| Q97071790 | Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain: Part 1, human and animal health |
| Q47289821 | Implementing the DF4 in a robust model, allowing for enhanced comparison, prioritisation and grouping of Nanomaterials. |
| Q51147702 | In Vitro and In Vivo Short-Term Pulmonary Toxicity of Differently Sized Colloidal Amorphous SiO₂. |
| Q29248121 | Influence of pH, particle size and crystal form on dissolution behaviour of engineered nanomaterials |
| Q57168448 | Nanomedicine: Principles, Properties, and Regulatory Issues |
| Q92711978 | Predicting dissolution and transformation of inhaled nanoparticles in the lung using abiotic flow cells: The case of barium sulfate |
| Q30376884 | Safety assessment of nanomaterials using an advanced decision-making framework, the DF4nanoGrouping. |
| Q90822017 | The Grouping and Assessment Strategy for Organic Pigments (GRAPE): Scientific evidence to facilitate regulatory decision-making |
| Q38379927 | Towards a nanospecific approach for risk assessment |
| Q89719184 | Understanding Dissolution Rates via Continuous Flow Systems with Physiologically Relevant Metal Ion Saturation in Lysosome |
Search more.